A new method of measuring tumor progression offers prognostic implications for patients with head and neck squamous cell carcinoma experiencing treatment delays.

News

Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don’t have these tumors, a recent study suggests.
In patients with hypopharyngeal and laryngeal cancers, the number of metastatic lymph nodes is independently associated with mortality, according to a recent study.
A recent comparative study examined whether chemotherapy alone is as effective as adjuvant radiotherapy plus chemotherapy in patients with high-risk grade 2 glioma.
Survivors of thyroid cancer who were younger than 40 years at diagnosis have a higher risk of developing age-related diseases compared with older patients or those who never had cancer.

Research in Review

A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial.

-----

Related Content

Read More

Response to a single dose of neoadjuvant chemotherapy indicates the optimal treatment course for patients with laryngeal cancer, according to a study published in JAMA Otolaryngology (published online February 2, 2017; doi:10.1001/jamaoto.2016.3669).

-----

Related Content

Read More

Positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate prior to surgery, says a new study.

-----

Related Content

Read More

Patients with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinomas may have higher chances of being cured if treated with reduced doses of radiation, according to a new study published in the Journal of Clinical Oncology.

-----

Related Content

Read More

Subscribe to Head & Neck Cancer